Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Chevron
CVX
|
+$317M |
| 2 |
Walmart Inc
WMT
|
+$218M |
| 3 |
Linde
LIN
|
+$174M |
| 4 |
PayPal
PYPL
|
+$133M |
| 5 |
Union Pacific
UNP
|
+$126M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$724M |
| 2 |
Uber
UBER
|
+$527M |
| 3 |
ExxonMobil
XOM
|
+$450M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$365M |
| 5 |
Apple
AAPL
|
+$336M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.8% |
| 2 | Healthcare | 17.12% |
| 3 | Consumer Discretionary | 13.21% |
| 4 | Financials | 8.81% |
| 5 | Consumer Staples | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIXC
3601
AIxCrypto Holdings Inc
AIXC
$13.4M
| $17K | ﹤0.01% |
+859
| New | +$20.1K |
|
3602
Rockwell Medical
RMTI
$28.4M
| $17K | ﹤0.01% |
1,051
-8,769
| -89% | -$127K |
|
|
AKLI
3603
DELISTED
Akili Inc
AKLI
| $17K | ﹤0.01% |
57,800
+35,500
| +159% | +$11.1K |
|
3604
Biofrontera
BFRI
$15M
| $16K | ﹤0.01% |
+10,221
| New | +$14.2K |
|
3605
Corvex Inc
MOVE
$299M
| $16K | ﹤0.01% |
361
-224
| -38% | -$15K |
|
3606
VerifyMe
VRME
$9.38M
| $16K | ﹤0.01% |
+11,700
| New | +$13.7K |
|
|
GLDG
3607
GoldMining Inc
GLDG
$178M
| $15K | ﹤0.01% |
17,500
-13,749
| -44% | -$11.5K |
|
3608
Moving iMage Technologies
MITQ
$5.27M
| $15K | ﹤0.01% |
32,000
-3,596
| -10% | -$2.67K |
|
|
NUTX
3609
Nutex Health
NUTX
$1.01B
| $15K | ﹤0.01% |
1,049
-2,096
| -67% | -$42.2K |
|
3610
TDH Holdings
PETZ
$12.2M
| $15K | ﹤0.01% |
+13,000
| New | +$14.9K |
|
|
DCOY
3611
Decoy Therapeutics
DCOY
$2.19M
| $15K | ﹤0.01% |
20
+2
| +11% | +$1.72K |
|
|
JXG
3612
JX Luxventure
JXG
| $15K | ﹤0.01% |
204
-11
| -5% | -$925 |
|
3613
Alzamend Neuro
ALZN
$6.28M
| $14K | ﹤0.01% |
153
+40
| +35% | +$3.43K |
|
3614
Bluejay Diagnostics
BJDX
$890K
| $14K | ﹤0.01% |
+11
| New | +$15.2K |
|
3615
Farmmi Inc
FAMI
$6.33M
| $14K | ﹤0.01% |
1,407
+25
| +2% | +$323 |
|
|
NXTP
3616
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
| $14K | ﹤0.01% |
20,749
+3,014
| +17% | +$3.74K |
|
|
IONM
3617
DELISTED
Assure Holdings Corp. Common Stock
IONM
| $14K | ﹤0.01% |
+1,606
| New | +$9.73K |
|
3618
CLPS Inc
CLPS
$25.6M
| $12K | ﹤0.01% |
11,332
+100
| +0.9% | +$102 |
|
3619
Kiora Pharmaceuticals
KPRX
$11.3M
| $12K | ﹤0.01% |
1,851
-227
| -11% | -$1.27K |
|
3620
SOBR Safe
SOBR
$1.52M
| $11K | ﹤0.01% |
+24
| New | +$14.3K |
|
|
SPI
3621
DELISTED
SPI Energy Co., Ltd. Ordinary Shares
SPI
| $11K | ﹤0.01% |
18,200
-1,500
| -8% | -$963 |
|
|
EDBL
3622
Edible Garden
EDBL
$1.49M
| – | – |
0
| – | – |
|
3623
InMed Pharmaceuticals
INM
$7.85M
| $10K | ﹤0.01% |
1,415
-530
| -27% | -$3.9K |
|
3624
Upexi
UPXI
$55.5M
| $10K | ﹤0.01% |
840
+305
| +57% | +$5.56K |
|
|
WLGS
3625
DELISTED
Wang & Lee Group
WLGS
| $10K | ﹤0.01% |
+16,995
| New | +$11.6K |
|
Similar funds
Renaissance Technologies's Q1 2024 Portfolio in Review
As of Q1 2024, Renaissance Technologies held 4,246 positions worth $63.6B, down 1.5% from $64.6B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies withdrew a net $5.25B in Q1 2024, closing 582 positions and reducing 1,517 holdings. Its most notable exit was ExxonMobil, an estimated $450M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Renaissance Technologies opened a new position in Chevron worth $331M.
- Renaissance Technologies's largest Q1 2024 buy was Chevron: 2,097,623 shares worth $331M.
- Renaissance Technologies added most to Walmart Inc in Q1 2024, an estimated $218M increase.
- Renaissance Technologies's biggest Q1 2024 reduction was NVIDIA, cutting an estimated $724M.
- Renaissance Technologies fully exited ExxonMobil in Q1 2024, selling an estimated $450M.
- Renaissance Technologies's ten largest holdings make up 12% of its $63.6B portfolio in Q1 2024.
- Renaissance Technologies opened 563 new positions and closed 582 in Q1 2024.
- Renaissance Technologies's portfolio value fell 1.5% quarter-over-quarter to $63.6B.
Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.